Page last updated: 2024-08-24

cidofovir anhydrous and Malignant Melanoma

cidofovir anhydrous has been researched along with Malignant Melanoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J	1
Calista, D	1
Raulin, J	1

Reviews

1 review(s) available for cidofovir anhydrous and Malignant Melanoma

Article	Year
Development in lipid drugs. Mini reviews in medicinal chemistry, 2005, Volume: 5, Issue:5 Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cidofovir; Cowpox virus; Cytosine; Dendritic Cells; Glycyrrhizic Acid; HIV-1; Humans; Lipids; Major Histocompatibility Complex; Melanoma; Organophosphonates; Orthopoxvirus; Peptides; Severe acute respiratory syndrome-related coronavirus; T-Lymphocytes	2005

Article

Year

Development in lipid drugs.

Mini reviews in medicinal chemistry, 2005, Volume: 5, Issue:5

Topics: Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cidofovir; Cowpox virus; Cytosine; Dendritic Cells; Glycyrrhizic Acid; HIV-1; Humans; Lipids; Major Histocompatibility Complex; Melanoma; Organophosphonates; Orthopoxvirus; Peptides; Severe acute respiratory syndrome-related coronavirus; T-Lymphocytes

2005

Other Studies

2 other study(ies) available for cidofovir anhydrous and Malignant Melanoma

Article	Year
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2022, 07-04, Volume: 32, Issue:7 Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms	2022
Regression of a cutaneous melanoma metastasis after intralesional cidofovir. Melanoma research, 2003, Volume: 13, Issue:2 Topics: Antineoplastic Agents; Cidofovir; Cytosine; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Organophosphonates; Organophosphorus Compounds; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome	2003

Article

Year

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2022, 07-04, Volume: 32, Issue:7

Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms

2022

Regression of a cutaneous melanoma metastasis after intralesional cidofovir.

Melanoma research, 2003, Volume: 13, Issue:2

Topics: Antineoplastic Agents; Cidofovir; Cytosine; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Organophosphonates; Organophosphorus Compounds; Remission Induction; Skin Neoplasms; Time Factors; Treatment Outcome

2003